Compare OBDC & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBDC | MIR |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Industrial Machinery/Components |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.7B |
| IPO Year | 2019 | N/A |
| Metric | OBDC | MIR |
|---|---|---|
| Price | $12.61 | $26.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $14.44 | ★ $28.29 |
| AVG Volume (30 Days) | ★ 4.3M | 2.2M |
| Earning Date | 02-18-2026 | 02-10-2026 |
| Dividend Yield | ★ 12.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.39 | 0.10 |
| Revenue | ★ $1,797,946,000.00 | $902,300,000.00 |
| Revenue This Year | $19.30 | $8.75 |
| Revenue Next Year | N/A | $23.17 |
| P/E Ratio | ★ $9.10 | $261.47 |
| Revenue Growth | ★ 11.43 | 7.82 |
| 52 Week Low | $11.65 | $12.00 |
| 52 Week High | $15.73 | $30.28 |
| Indicator | OBDC | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 61.30 |
| Support Level | $12.48 | $23.89 |
| Resistance Level | $12.74 | $27.10 |
| Average True Range (ATR) | 0.24 | 0.84 |
| MACD | -0.00 | 0.33 |
| Stochastic Oscillator | 56.15 | 76.95 |
Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.